Abstract
Background: The exclusion of axillary lymph node clearance (ALNC) in patients with breast carcinoma when sentinel lymph node biopsy (SLNB) comes back negative has reduced arm morbidity and lymphedema significantly. The rate of axillary recurrence is substantially lower than expected in the early follow-up reports with a median false-negative rate of 6.7 per cent for SNB. Axillary recurrences may develop late therefore, long-term follow up reports are needed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
